|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2006-08-25- -2006-10-19 Sale |
2007-04-30 9:04 pm | ORCHESTRA THERAPEUTICS, INC. | OCHT | THEOFAN GEORGIA (VP, Clinical Development) | 3,750,000 | $2 | $7,500,000 | 90,529 (Direct) | View |
| 2004-08-11 Purchase(A) |
2004-08-12 2:00 pm | IMMUNE RESPONSE CORP | IMNR | THEOFAN GEORGIA (VP, Clinical Development) | 5,000 | $0.7 | $3,500 | 10,475 (Direct) |
View |
| Transaction & Date |
Reported Date |
Company | Symbol | Insider Relationship | Shares Traded | Average Price |
Total Amount | Shares Ownership |
Filing |
| 2005-12-30- -2006-09-30 Option Award |
2006-10-23 6:52 pm | IMMUNE RESPONSE CORP | IMNR | THEOFAN GEORGIA (VP, Clinical Development) | 60,900 | $0.03269 | $1,991 | 90,529 (Direct) |
View |
| 2005-09-30 Option Award |
2005-10-05 5:57 pm | IMMUNE RESPONSE CORP | IMNR | THEOFAN GEORGIA (VP, Clinical Development) | 5,389 | $0.46 | $2,479 | 29,629 (Direct) |
View |
| 2005-06-30 Option Award | 2005-08-10 5:06 pm |
IMMUNE RESPONSE CORP | IMNR | THEOFAN GEORGIA (VP, Clinical Development) | 5,385 | $0.65 | $3,500 | 24,240 (Direct) | View |
| 2005-03-31 Option Award | 2005-04-08 7:34 pm |
IMMUNE RESPONSE CORP | IMNR | THEOFAN GEORGIA (VP, Clinical Development) | 3,926 | $0.78 | $3,062 | 18,855 (Direct) |
View |
| 2004-12-31 Option Award | 2005-01-19 6:18 pm |
IMMUNE RESPONSE CORP | IMNR | THEOFAN GEORGIA (VP, Clinical Development) | 1,902 | $1.61 | $3,062 | 14,929 (Direct) | View |
| 2004-09-30 Option Award | 2004-10-04 7:11 pm | IMMUNE RESPONSE CORP | IMNR | THEOFAN GEORGIA (VP, Clinical Development) | 2,552 | $1.2 | $3,062 | 13,027 (Direct) |
View |
| 2004-08-11 Option Award |
2004-08-11 12:54 pm | IMMUNE RESPONSE CORP | IMNR | THEOFAN GEORGIA (VP, Clinical Development) | 5,000 | $0.7 | $3,500 | 10,475 (Direct) | View |
| 2004-06-30 Option Award |
2004-07-23 2:09 pm |
IMMUNE RESPONSE CORP | IMNR | THEOFAN GEORGIA (VP, Clinical Development) | 2,832 | $1.22 | $3,455 | 5,475 (Direct) |
View |
| 2004-06-01 Option Award |
2004-06-03 5:00 pm |
IMMUNE RESPONSE CORP | IMNR | THEOFAN GEORGIA (VP, Clinical Development) | 1,543 | $1.57 | $2,423 | 2,643 (Direct) | View |
| Transaction & Date |
Reported Date | Exercisable Expiration |
Company | Symbol | Insider Relationship | Shares Traded | Conversion Price | Shares Ownership |
Filing |
| 2007-03-30 Expired |
2007-04-30 9:04 pm | 2006-10-16 N/A |
ORCHESTRA THERAPEUTICS, INC. | OCHT | THEOFAN GEORGIA (VP, Clinical Development) | 37,500 | $2 | 0 (Direct) |
View |
| 2006-08-07 Exercise |
2006-08-09 8:32 pm | 2006-03-07 2006-11-30 | IMMUNE RESPONSE CORP | IMNR | THEOFAN GEORGIA (VP, Clinical Development) | 3,750,000 | $0.02 | 3,750,000 (Direct) | View |
| 2006-08-07 Exercise | 2006-08-09 8:31 pm | 2006-03-07 2006-11-30 | IMMUNE RESPONSE CORP | IMNR | THEOFAN GEORGIA (VP, Clinical Development) | 3,750,000 | $0.02 | 3,750,000 (Direct) |
View |
| 2006-03-07 Option Award |
2006-03-09 3:19 pm | N/A N/A | IMMUNE RESPONSE CORP | IMNR | THEOFAN GEORGIA (VP, Clinical Development) | 50,000 | $0.02 | 50,000 (Direct) |
View |
| 2006-03-07 Option Award |
2006-03-09 3:19 pm | N/A N/A |
IMMUNE RESPONSE CORP | IMNR | THEOFAN GEORGIA (VP, Clinical Development) | 7,500,000 | $0.02 | 7,500,000 (Direct) | View |
| 2005-07-18 Option Award |
2005-07-20 6:25 pm |
2005-07-18 2015-07-18 | IMMUNE RESPONSE CORP | IMNR | THEOFAN GEORGIA (VP, Clinical Development) | 100,000 | $0.74 | 100,000 (Direct) |
View |
|
© 2005-2008 SecForm4.Com All rights reserved. Archives: 2008 2007 2006 2005 2004 2003 Tue, 02 Dec 2008 18:54:31 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |